Brief: Regeneus Granted New Patent To Target Pain In Japan
Feb 9 (Reuters) - Regeneus Ltd RGS.AX :
* REGENEUS TO BE GRANTED NEW PATENT TO TARGET PAIN IN JAPAN
* JAPANESE PATENT OFFICE DECIDED TO GRANT CO NEW KEY PATENT
COVERING USE OF ITS LEAD STEM CELL TECHNOLOGY PROGENZA
Source: https://bit.ly/3tA9nJX
Further company coverage: RGS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cambium Bio
See all newsAustralia's Cambium Bio hits near three-month high on share placement at premium
Brief: Cambium Bio Appoints Olga Smejkalova As Company Secretary
Australia's Cambium Bio gains after premium share placement
Brief: Cambium Bio Raises A$1 MLN At A$0.48 Per Share
Brief: Cambium Bio Receives A$2.4 Million Investment From Zheng Yang Biomedical Technology